A Clinical Study of a New Sulfonamide (Nu-445) in The Treatment of Urinary Tract Infections

Abstract

No AccessJournal of Urology1 Mar 1949A Clinical Study of a New Sulfonamide (Nu-445) in The Treatment of Urinary Tract Infections Joseph A. Lazarus, and Lewis H. SchwarzB.S. Joseph A. LazarusJoseph A. Lazarus More articles by this author , and Lewis H. SchwarzLewis H. Schwarz More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(17)69119-5AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail © 1949 by The American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsCited ByShoemaker E and Yow E (2018) The Effect of Gantrisin on Prothrombin ActivityJournal of Urology, VOL. 72, NO. 1, (87-88), Online publication date: 1-Jul-1954.Creevy C and Price W (2018) Chloromycetin and Gantrisin in the Treatment of Urinary InfectionsJournal of Urology, VOL. 72, NO. 6, (1233-1237), Online publication date: 1-Dec-1954.Speas Phillips C and Lloyd F (2018) Urinary Tract Infections: Experience with Elkosin Journal of Urology, VOL. 72, NO. 6, (1247-1254), Online publication date: 1-Dec-1954.Stewart B and Lash J (2018) The Clinical Use of NU-445 (Gantrisin) in the Treatment of Urinary Tract Infections A Report of 100 CasesJournal of Urology, VOL. 64, NO. 6, (801-810), Online publication date: 1-Dec-1950. Volume 61Issue 3March 1949Page: 649-657 Advertisement Copyright & Permissions© 1949 by The American Urological Association Education and Research, Inc.MetricsAuthor Information Joseph A. Lazarus More articles by this author Lewis H. Schwarz More articles by this author Expand All Advertisement PDF DownloadLoading ...